Koch Industries’s CONMED CNMD Stock Holding History

Koch Industries’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,572	Closed	-$353K	–	141
2018 Q1	$353K	Buy	5,572 +168	+3%	+$10K	0.04%	567
2017 Q4	$275K	Buy	+5,404	New	+$281K	0.04%	486

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Koch Industries's CNMD Position: Q2 2018 in Review

Koch Industries sold out of CONMED (CNMD) in Q2 2018, closing a stake of 5,572 shares — an estimated $353K sold.

Koch Industries first reported a position in CNMD in Q4 2017 and held it in 2 quarters. The position peaked at $353K in Q1 2018. 196 funds tracked by Wall St. Rank hold CNMD as of Q2 2018.

Koch Industries reported no remaining CONMED position as of Q2 2018 after selling out during the quarter.
Koch Industries sold 5,572 CONMED shares in Q2 2018, an estimated $353K.
Koch Industries first reported a position in CONMED in Q4 2017 and held it in 2 quarters.
Koch Industries's CONMED position peaked at $353K in Q1 2018.
196 funds tracked by Wall St. Rank held CONMED as of Q2 2018.

Based on Koch Industries's 13F filing for Q2 2018, filed 13 Aug 2018.